20
Participants
Start Date
June 1, 2023
Primary Completion Date
January 1, 2024
Study Completion Date
February 20, 2024
Freshly manufactured 35 kDa hyaluronan fragment
The study was an open-label clinical trial. A pre- and posttreatment controlled study approach was used, whereby the investigator injected 35 kDa hyaluronan fragment HA35 into the periodontal pocket in a single dose of 100 mg. The distribution of the injection amount was determined by the location of gingival inflammation.
Huinuode Biotechnology Co., Ltd., Qingdao
Dove Medical Press Ltd
NETWORK